Furthermore, KEGG pathway enrichment analysis provided the same result that the PI3K/Akt signaling pathway participated in the effects of Nar against diabetic angiopathies as in the network pharmacology and transcriptomic sequencing analyses (Figures 6E, 7E). The gene discussed is AKT1; the disease is diabetic peripheral angiopathy.